Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI.

scientific article published on 14 June 2019

Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12885-019-5767-1
P932PMC publication ID6570957
P698PubMed publication ID31200687

P2093author name stringJin Wang
Jun Yang
Ming Chen
Wei Xu
Gang Xu
Zhenhua Wang
Xiao Hu
Yuchen Li
Xiuqin Zhang
Guofu Chen
Yujin Xu
Huarong Tang
Feiyan Zhang
Guoping Shan
Guiming Yan
Baiqiang Dong
P2860cites workEffect of immobilization and performance status on intrafraction motion for stereotactic lung radiotherapy: analysis of 133 patients.Q45400355
Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experienceQ48747629
Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.Q51605555
Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.Q53110784
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.Q53456532
Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMRT.Q55073350
Comparative analysis of thermoplastic masks versus vacuum cushions in stereotactic body radiotherapyQ30404155
No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236Q33758565
Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancerQ33813917
Stereotactic body radiation therapy for inoperable early stage lung cancerQ34010065
Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumorsQ35245587
Errors and margins in radiotherapyQ35643581
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional studyQ36866000
Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapyQ37465029
Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implicationsQ37675308
Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancerQ37884875
Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohortQ38152867
Sci-Thur AM: Planning - 06: Planning target volume margin suitability in lung stereotactic body radiation therapy: A preliminary evaluation using cone-beam computed tomographyQ38779341
Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort.Q40423339
Positioning accuracy for lung stereotactic body radiotherapy patients determined by on-treatment cone-beam CT imagingQ42246538
Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frameQ45157055
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)583
P577publication date2019-06-14
P1433published inBMC CancerQ326300
P1476titleChoice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI.
P478volume19